A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: Safety, tolerability and feasibility

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Sprigg, Nikola ^a   Gray, Laura J ^a   England, Tim ^a   Willmot, Mark R ^a   Zhao, Lian ^a   Sare, Gillian M ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; ANEMIA; ARTICLE; BLEEDING; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEASIBILITY STUDY; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; LONG TERM CARE; MALE; MONOTHERAPY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA VEIN OCCLUSION; SECONDARY PREVENTION; SINGLE BLIND PROCEDURE; STOMACH SPASM; TRANSIENT ISCHEMIC ATTACK; AGED; BLOOD PRESSURE; DRUG COMBINATION; DRUG EFFECT; DRUG TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PULSE RATE; SAFETY; STROKE;

AGED; ASPIRIN; BLOOD PRESSURE; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEASIBILITY STUDIES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PULSE; SAFETY; SINGLE-BLIND METHOD; STROKE; TICLOPIDINE;

EID: 51349157097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002852     Document Type: Article

References (22)

1. Bhatt DL, Kapadia SR, Yadav JS, Topol EJ (2000) Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Cerebrovascular Diseases 10: 34-40.
2. Antithrombotic Trialists Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324: 71-86.
3. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329-1339.
4. Diener HC, Cunha L, Forbes C, Sivenius J, Sivenius P, et al. (1996) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurological Sciences 143: 1-13.
5. The ESPRIT Study Group (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 367: 1665-1673.
6. ESPS Group (1990) European Stroke Prevention Study. Stroke 21: 1122-1130.
7. Yusuf S, Fox KAA, Tognoni G, Mehta SR, Chrolavicius S, et al. (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine 345:494-502.
8. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, et al. (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288: 2411-2420.
9. Bhatt DL, Fox KAA, Werner Hacke CB, Berger PB, Black HR, et al. (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England Journal of Medicine 354.
10. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, et al. (2005) Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. The clopidogrel and aspirin for reduction of emboli in syptomatic carotid stenosis (CARESS) trial. Circulation 111: 2233-2240.
11. Kennedy J, Hill MD, Ryckborst K, Elliaziw M, Demchuk mAM, et al. (2007) Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurology 6: 961-969.
12. Zhao L, Bath P, Heptinstall S (2001) Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. British Journal Pharmacology 131: 353-358.
13. Zhao L, Fletcher S, Weaver C, Leonardi-Bee J, May J, et al. (2005) Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and lecocyte function in normal volunteers and patients with prior ischaemic stroke. Thromb Haemost 93: 527-534.
14. Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener H-C, et al. (2005) Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke 36: 162-168.
15. Zhao L, Gray LJ, Leonardi-Bee J, Weaver CS, Heptinstall S, et al. (2006) Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patiens with prior ischaemic stroke. Platelets 17: 100-104.
16. Gryglewski RJ, Dupin JP, Uracz W, Swies J, Madej J, et al. (2000) Thrombolysis by thienopyridines and their congeners. Journal of Physiology & Pharmacology 51: 683-693.
17. Willmot M, Zhao L, Heptinstall S, Bath PMW (2004) Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke. J Stroke Cerebrovasc Dis 13: 138-140.
18. Weir CJ, Lees KR (2003) Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. StatMed 22: 705-726.
19. Bath PM, Geeganage C, Gray LJ, Collier T, Pocock S (2008) Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published trials. Stroke [In Press].
20. (NICE) NIfHaCE (2005) Clopidogrel and modifiedrelease dipyridamole in the prevention of occlusive vascular events. National Institute for Health and Clincal Excellence.
21. Hegedus K, Keresztes T, Fekete I, Molnar L (1997) Elect of i.v. dipyridamole on cerebral blood flow, blood pressure, plasma adenosine and cAMP levels in rabbits. Journal of the Neurological Sciences 148: 153-161.
22. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, et al. (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364: 331-337.